Connected With the Companies Defining the Future of In Vivo CAR-T Therapeutics
The 5th In Vivo Cell Engineering & Gene Editing Summit rapidly evolved into a focal meeting point for in vivo delivery innovation. As the field accelerated from preclinical promise to clinical validation, the summit brought together the decision-makers driving next-generation in vivo cell and genome editing therapies, creating valuable opportunities for collaboration, partnership, and scientific exchange.
Momentum across the field was underscored by Eli Lilly’s landmark partnership with Kelonia Therapeutics, the largest in vivo CAR-T deal to date, signaling strong pharma commitment to scalable, in vivo approaches to cell therapy. And with Intellia Therapeutics racing towards FDA approval for their in vivo CRISPR Therapy, the industry continued to reach significant milestones throughout the year.
Partnering for the 6th In Vivo Cell Engineering & Gene Editing Summit positions your company alongside the innovators shaping the future of in vivo cell and genome engineering and ensures your brand remains front of mind as developers prepare the next wave of in vivo programs.
In Vivo CAR-T: The Deal-Making Hotspot in Cell Therapy
Across 2025 and 2026, the in vivo CAR-T landscape has seen accelerating deal activity, reflecting strong commercial validation from biopharma and investment communities.
Key highlighted transactions include:
- Eli Lilly & Kelonia Therapeutics (2026) – Largest in vivo CAR-T deal to date
- AbbVie & Capstan Therapeutics (2025) – Strategic acquisition strengthening in vivo CAR-T pipelines
- Transactions involving Kite Pharma, Bristol Myers Squibb, and AstraZeneca are reinforcing competitive urgency
This surge in deal-making is driving demand for delivery technologies, CDMO scale-up, and translational expertise across the in vivo CAR-T ecosystem.
What to Expect as a Partner in 2027?
Meet High‑Intent Prospects
Engage face‑to‑face with R&D, translational, CMC, and business development leaders seeking partners for manufacturing, delivery optimization, analytical development, safety testing, and IND‑enabling support.
Strengthen Your Position in a Competitive Market
Place your brand directly in front of companies preparing the next wave of editing, delivery, and early clinical programs, ensuring your organization is seen as ready to support this shift.
Demonstrate Your Expertise
Showcase your capabilities through speaking opportunities, panel participation, or a tailored exhibition presence designed to highlight your unique strengths in supporting in vivo development.
Gain Real‑Time Market Intelligence
Key Interest Areas the 2026 Summit
Our attendees are actively seeking partners with capabilities across the in vivo development ecosystem, including but not limited to the areas below.
Non-Viral Vector CDMOs & Technology Providers
Acrpss lipid nanoparticles (LNPs), novel delivery systems, targeting and cell-specific uptake solutions enabling in vivo CAR-T
Viral Vector CDMOs & Technology Providers
Specializing in optimized AAV and lentiviral platforms supporting in vivo gene delivery
Global CRO Organizations
From preclinical through early clinical support for in vivo cell and gene pipelines
Preclinical Model Providers
Across relevant disease and immune models, validating in vivo efficacy and safety
Other Solutions for In Vivo Drug Developers
Including analytics, CMC, regulatory, and enabling technologies
Position Yourself at the Center of In Vivo Cell & Gene Pipeline Progression
As in vivo delivery for cell therapy transitions from an experimental concept to an investable modality, we can position your organization at this summit to demonstrate leadership and relevance in one of the most competitive areas of precision medicine. Align your brand with the companies shaping the next wave of immuno-oncology and autoimmune therapeutics.
Audience Composition
Company Type
Attendee Seniority
Attending Companies Included
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jake Bennett
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.